Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
AbCellera Biologics Inc (NASDAQ: ABCL) closed the day trading at $3.02 up 20.32% from the previous closing price of $2.51. In other words, the price has increased by $20.32 from its previous closing price. On the day, 17.47 million shares were traded.
Ratios:
For a better understanding of ABCL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.15 and its Current Ratio is at 10.15. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On December 05, 2023, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $6.KeyBanc Capital Markets initiated its Overweight rating on December 05, 2023, with a $6 target price.
Stock Price History:
Over the past 52 weeks, ABCL has reached a high of $3.68, while it has fallen to a 52-week low of $1.89. The 50-Day Moving Average of the stock is 34.55%, while the 200-Day Moving Average is calculated to be 13.96%.
Shares Statistics:
A total of 298.36M shares are outstanding, with a floating share count of 223.95M. Insiders hold about 24.97% of the company’s shares, while institutions hold 41.07% stake in the company.
